Portaero still looking for $182K to treat emphysema

Portaero, developer of a device used to treat chronic obstructive pulmonary diseases — particularly emphysema — has raised the bulk of its targeted $12 million round of equity, according to regulatory filings. It is still short $182,000. Based in Cupertino, Calif., the company, which lacks a web site, has taken capital from Aberdare Ventures, Novartis Venture Funds and Versant Ventures.

Next Story: Vapore raises $348K to turn liquid medicines into vapors
Previous Story: M2 Group scores $6M for devices to treat diabetes